The concept of disease modification in spondyloarthropathy

Journal of Rheumatology

Volumn 29, Issue 8, 2002, Pages 1583-1585

  Marzo Ortega, Helena ^a   Emery, Paul ^a   McGonagle, Dennis ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; ETANERCEPT; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT;

ANKYLOSING SPONDYLITIS; ANKYLOSIS; BONE DEFORMATION; BONE DESTRUCTION; BONE INJURY; BONE RADIOGRAPHY; DIAGNOSTIC IMAGING; EDITORIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEITIS; OSTEOSCLEROSIS; OUTCOMES RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVITIS; VALIDATION PROCESS; COMPARATIVE STUDY; HUMAN; METHODOLOGY; NOTE; PATHOLOGY; RHEUMATOLOGY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COMPARATIVE STUDY; HUMAN; RHEUMATOLOGY; SPONDYLITIS, ANKYLOSING; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0036021117     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Role of disease-modifying anti-rheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis
2. Randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
3. Recent rheumatoid arthritis clinical trials using radiographic endpoints - Updated research agenda
4. Infliximab in the treatment of rheumatoid arthritis
5. Intra-articular corticosteroids prevent progression of erosions in methotrexate treated early RA. An MRI/HRUS study
6. Disease controlling antirheumatic therapy in spondyloarthropathy
7. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year follow up
8. Use of dynamic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondyloarthropathy patients
9. Fat suppressed MRI in spinal disease in early spondyloarthropathy
10. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondyloarthropathy
11. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
12. A trial of etanercept, a recombinant tumour necrosis factor receptor:Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate
13. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab
14. Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomised trial
15. Crohn's disease associated with spondyloarthropathy: Effect of TNF-alpha blockade (infliximab) on the articular symptoms
16. Efficacy of etanercept in the entheseal pathology in spondyloarthropathy
17. Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis
18. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy
19. Pathology of spondyloarthropathies
20. Histopathology of murine ankylosing enthesopathy
21. Enthesopathy of rheumatoid and ankylosing spondylitis
22. Ankylosing spondylitis
23. Report on the Fourth International Workshop on Reactive Arthritis
24. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study
25. Infliximab in ankylosing spondylitis: A prospective observational inception cohort analysis of efficacy and safety